Joseph Gulfo
Plus aucun poste en cours
Profil
Joseph V.
Gulfo served as Chairman, President & CEO of STRATA Skin Sciences, Inc. from 2011 to 2013 and as Chairman, President & CEO of NuGenerex Immuno-Oncology, Inc. from 1999 to 2003.
He also held positions as Chairman of Atropos Technologies LLC, Director of ProCertus BioPharm, Inc., Chief Operating Officer of Anthra Pharmaceuticals, Inc., and Strategic Advisor of Medicus Sciences Acquisition Corp.
Gulfo holds a doctorate from the University of Medicine & Dentistry of New Jersey and undergraduate and MBA degrees from Seton Hall University.
Anciens postes connus de Joseph Gulfo
| Sociétés | Poste | Fin |
|---|---|---|
| STRATA SKIN SCIENCES, INC. | Directeur Général | 15/06/2013 |
| NUGENEREX IMMUNO-ONCOLOGY, INC. | Président | 01/11/2003 |
| MEDICUS SCIENCES ACQUISITION CORP. | Corporate Officer/Principal | - |
Atropos Technologies LLC
 Atropos Technologies LLC BiotechnologyHealth Technology Atropos Technologies LLC provides life sciences research and medical device technologies. Its services include consulting, fund raising, business planning, and development. The firm offers cell printers, micro plate cell incubators, microarray hybridization systems, oligo synthesizers, microarrayers, MIAS-2, and eaZYX imaging products. The company is based in Canton, MA. | Président | - |
ProCertus BioPharm, Inc.
 ProCertus BioPharm, Inc. Pharmaceuticals: MajorHealth Technology ProCertus BioPharm, Inc. operates as an oncology-based pharmaceutical company. Its product includes DermX, ProDermaCel, and OralX, proprietary pharmaceuticals which are designed to reduce or eliminate the side effects associated with cancer therapy. ProDermaCel will protect cancer patients from chemotherapy- and radiotherapy-induced alopecia (hair loss), DermX will prevent radiotherapy-induced dermatitis (skin burn), and OralX will protect against chemotherapy- and radiotherapy-induced oral mucositis. The company was founded by William E. Fahl and in 1997 and is headquartered in Madison, WI. | Directeur/Membre du Conseil | - |
Formation de Joseph Gulfo
| Seton Hall University | Masters Business Admin |
| University of Medicine & Dentistry of New Jersey | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| STRATA SKIN SCIENCES, INC. | Health Technology |
| Entreprise privées | 5 |
|---|---|
Anthra Pharmaceuticals, Inc.
 Anthra Pharmaceuticals, Inc. Medical DistributorsDistribution Services Anthra Pharmaceuticals, Inc. is an American company. | Distribution Services |
NuGenerex Immuno-Oncology, Inc.
 NuGenerex Immuno-Oncology, Inc. BiotechnologyHealth Technology NuGenerex Immuno-Oncology, Inc. is an oncology company focuses on the modulation of the immune system to treat cancer. It develops immunotherapeutic products and vaccines based on proprietary, patented platform technology, Ii-Key. The Ii-Key is a peptide derived from the major histocompatibility complex (MHC) class II associated invariant chain that regulates the formation, trafficking, and antigen-presenting functions of MHC class II complexes, essential for the activation of T cells in the immune response. The company was founded on October 8, 1993 and is headquartered in Miramar, FL. | Health Technology |
ProCertus BioPharm, Inc.
ProCertus BioPharm, Inc. Pharmaceuticals: MajorHealth Technology ProCertus BioPharm, Inc. operates as an oncology-based pharmaceutical company. Its product includes DermX, ProDermaCel, and OralX, proprietary pharmaceuticals which are designed to reduce or eliminate the side effects associated with cancer therapy. ProDermaCel will protect cancer patients from chemotherapy- and radiotherapy-induced alopecia (hair loss), DermX will prevent radiotherapy-induced dermatitis (skin burn), and OralX will protect against chemotherapy- and radiotherapy-induced oral mucositis. The company was founded by William E. Fahl and in 1997 and is headquartered in Madison, WI. | Health Technology |
Atropos Technologies LLC
Atropos Technologies LLC BiotechnologyHealth Technology Atropos Technologies LLC provides life sciences research and medical device technologies. Its services include consulting, fund raising, business planning, and development. The firm offers cell printers, micro plate cell incubators, microarray hybridization systems, oligo synthesizers, microarrayers, MIAS-2, and eaZYX imaging products. The company is based in Canton, MA. | Health Technology |
Medicus Sciences Acquisition Corp.
 Medicus Sciences Acquisition Corp. Financial ConglomeratesFinance Medicus Sciences Acquisition Corp. operates as a blank check company. It was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses for its initial business. The company was founded on November 26, 2020 and is headquartered in New York, NY. | Finance |
